SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

Quality Corner: IRB Continuing Review, an Important Reminder!

October 24, 2019 - SCI Communications

We have an obligation when submitting for protocol renewal to include information about any noncompliance that has occurred over the last year of research conduct. This includes regulatory noncompliance and deviations.

This is essential for the accountability, correction of non-compliance, prevention of reoccurrences, adherence to the ethical standards, and integrity of the clinical trial.

In eProtocol, where to enter noncompliance in the Continuing Review/Renewal submission?

Helpful Tip! Use OnCore as your deviation log to document ALL protocol deviations. When entered into OnCore you are able to run a PDF report of your study’s deviations that can be attached to the IRB renewal submission! Ensure you specify in 2g what section the PDF is attached.

If you have any questions or concerns, please email dsmc-quality@stanford.edu.

References: HRPP Policy Manual

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube